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To the Editor:
We congratulate Yao et al [1] on their valuable contribution to
the area of nutritional supplementation to maximize visual
performance. In brief, Yao et al conducted a randomized,
double-blind, placebo-controlled trial of patients supplemented
with 20mg of lutein daily versus placebo, and found that supple-
mentation with 20 mg of lutein per day resulted in improve-
ments in terms of contrast sensitivity and glare disability,
especially under mesopic conditions.
Indeed, the findings of Yao et al are consistent with the
growing evidence base in this area, which indicates that high
levels of macular pigment are required for visual excellence in
normal individuals [2].
Macular pigment is made up of three carotenoids, lutein (L),
zeaxanthin (Z), and meso-zeaxanthin (MZ), MZ being the domi-
nant carotenoid at the visual center, where visual performance
and sensitivity is maximal [3]. A recent randomized, placebo-
controlled trial of differing carotenoid formulations versus
placebo (also in normal participants), revealed that a formulation
containing MZ resulted in the greatest improvements in visual
performance (contrast sensitivity, under mesopic and photopic
conditions, under and not under conditions of glare), whereas
only minimal benefits were noted with the supplementation
lacking the centrally dominant carotenoid (MZ); no visual
improvements were noted in participants who were supple-
mented with placebos [4].
The finding that MZ is required in a formulation to maximally
improve visual performance is unsurprising, given that 12% of the
population has a central dip in the spatial profile of their macular
pigment [5], and that in these individuals the normal, centrally
peaked spatial profile of macular pigment can only be realized
following supplementation with a formulation that contains all
three of macular pigment’s constituent carotenoids (MZ, L,
andZ in a ratioof 10:10:2) [6]. Also, thenecessityofMZ in a formu-
lation to maximally enhance visual performance is consistent
with a recent serum study, where it was shown that a preparation
containing all three macular carotenoids was required if serum
bioavailability of macular pigment’s constituent carotenoids
was to bemaximized, and therefore enhance capture by the target
tissue (macula) of these circulating compounds [7].
In summary, and again, we congratulate Yao et al for their
excellent piece of work and contribution to this growing area of
research. However, we believe that a formulation designed to
optimize visual performance should include all three of macular
pigment’s constituent carotenoids in a MZ:L:Z ratio of 10:10:2.
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Higher dose lutein and a longer
supplementation period would be
good for visual performanceTo the Editor:
We appreciate the comments by Drs. John Nolan, Stephen
Beatty, and Jessica Dennison about our article [1]. They suggest
that a formulation designed to optimize visual performance
should include all three of macular pigment’s (MP) constituent
carotenoids in a meso-zeaxanthin (MZ) to lutein (L) to zeaxan-
thin (Z) ratio of 10:10:2 [2]. We agree that MP is made up of
the three carotenoids, L, Z, and MZ, and that MZ does play an
important role in improving visual performance [3].
Very recently, Ma et al. [4] conducted a randomized, double-
masked, placebo-controlled trial that revealed that macular
pigment optical density (MPOD) increased significantly both in
the 20-mg L group (without MZ) and the L and Z group (without
MZ), and there was a significant between-group difference in
contrast sensitivity (CS) at three and six cycles per degree between
the20-mgLgroupand theplacebogroup.Huanget al [5] found that
serum lutein levels in theHL (20-mg lutein) group increased signif-
icantly in thefirst 4wk, andMPOD increased significantly at 24 and
48 wk. Based on the previous study, retinal MZ is primarily gener-
ated from isomerization of retinal L (but not Z) [6]. Participants
who are unable to convert L to MZ at this location led to a central
dip MPOD spatial profile are in the minority [7]. So we believe, L
supplementation can improve human visual performance, even
withoutMZ. Indeed, it may take higher doses and a longer supple-
mentation period.
We choose 20-mg L as the intervention factor also for con-
sumption psychological factors [8]. We conducted an unpub-
lished survey of 200 L consumers in different age groups in
Shanghai. The options included L, Z, MZ and the combination,
but the Z or MZ formulations were more expensive. The survey
indicated that 90% of respondents tended to buy the higher-
